Clin2
NCT06799039Possibly a fitNot yet recruiting

Xylitol to reduce C. difficile bacteria in inflammatory bowel disease

Inflammatory Bowel Disease (IBD)Clostridioides Difficile Infection

Part of Digestive system, Infections clinical trials.

This trial tests whether a natural sweetener called xylitol (taken by mouth) can help reduce the amount of C. difficile bacteria in your gut, which may help prevent infection. If you have mild or inactive IBD and are planning a routine appointment, you may be able to join.

Summary written for real people, not researchers, by Clin2.

Phase
Early Phase 1
Enrollment
69 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 years or older.
  • You have inflammatory bowel disease (Crohn's disease, ulcerative colitis, or indeterminate colitis).
  • Your IBD is inactive or mild (not causing severe symptoms).
  • You are scheduled for an outpatient colonoscopy or a clinic appointment.
  • You have not had colon surgery (excluding appendix removal).
  • You are not taking antibiotics on a regular basis and can swallow capsules.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT05852587Not yet recruiting· Phase 1
Xylitol capsules to clear C. difficile in people with IBD

This study tests whether taking xylitol (a natural sweetener) in capsule form can help clear a harmful gut bacteria called C. difficile from people with IBD. If you have mild or inactive IBD, this might be a simple way to reduce that bacteria and potentially prevent future infections.

Boston, Massachusetts
NCT06794944Not yet recruiting· Phase 4
Comparing two antibiotics to clear C. difficile in inflammatory bowel disease

This study tests two antibiotics—fidaxomicin and vancomycin—to see which is better at clearing C. difficile bacteria from the gut in people with inflammatory bowel disease. If you are having a colonoscopy, you may be able to participate.

Boston, Massachusetts
NCT06884748Not yet recruiting· Early Phase 1
Adding bile acid treatment to prevent C. diff from returning

This study tests whether adding a common bile acid (ursodeoxycholic acid) to your regular C. diff treatment can help stop the infection from coming back. The goal is to see if this extra medicine reduces the chance of recurrence.

Milwaukee, Wisconsin
NCT07411131Not yet recruiting
Synbiotic supplement for mild ulcerative colitis

This study tests a new food supplement (a synbiotic, which combines good bacteria and food for them) to see if it helps control symptoms of ulcerative colitis, a type of inflammatory bowel disease. If you have mild to moderate ulcerative colitis, this supplement might help reduce inflammation and improve your gut health.

Hong Kong
NCT07613645Recruiting
Lifestyle changes to prevent recurring C. difficile infection

This study tests whether specific lifestyle changes during treatment for C. difficile infection (a serious gut bacteria infection) can help prevent it from coming back. You'll receive standard antibiotic treatment and follow a controlled diet while researchers track your recovery.

Ann Arbor, Michigan
NCT06781827Recruiting
Probiotics for newly diagnosed IBD

This study tests whether taking probiotics can help prevent or treat inflammatory bowel disease (IBD) in people recently diagnosed. It aims to see if friendly bacteria can calm gut inflammation and improve symptoms.

Suqian, Jiangsu

Hear when a new Clostridioides Difficile Infection trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.